Translational Development Acquisition Corp. · NASDAQ:TDAC
Meteora Capital, LLC reported a 6.27% stake in Translational Development Acquisition Corp. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 14, 2026
Meteora Capital, LLC reported a 6.27% stake in Translational Development Acquisition Corp., 919,000 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 6.27%
- Shares
- 919,000
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Meteora Capital, LLC | 6.27% | 919,000 |
Source
Related
- Translational Development Acquisition Corp.
- Meteora Capital, LLC
- Translational Development Acquisition Corp. shareholders
- Schedule 13G/A · Linden Advisors LP · Aug 14, 2026
- Schedule 13G/A · Goldman Sachs Group Inc · Aug 12, 2026
- Schedule 13G/A · Wolverine Asset Management LLC · Jul 16, 2026
- Schedule 13G · Linden Advisors LP · Jun 2, 2026
- Schedule 13G · Goldman Sachs Group Inc · May 13, 2026